Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
about
The Association between Nutritional Markers and Biochemical Parameters and Residual Renal Function in Peritoneal Dialysis PatientsRole of residual renal function in phosphate control and anemia management in chronic hemodialysis patientsPeritoneal membrane phosphate transport status: a cornerstone in phosphate handling in peritoneal dialysisFibroblast growth factor 23 in patients undergoing peritoneal dialysisHyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients.Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal functionPeritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.Infrequent dialysis: a new paradigm for hemodialysis initiation.Is valvular calcification a part of the missing link between residual kidney function and cardiac hypertrophy in peritoneal dialysis patients?The importance of residual renal function in chronic dialysed patients.Can we reduce the cardiovascular risk in peritoneal dialysis patients?Vascular and valvular calcification in chronic peritoneal dialysis patients.Strategies for the preservation of residual renal function in pediatric dialysis patients.Hyperphosphatemia among end-stage renal disease patients in developing countries: a forgotten issue?Vascular calcification and cardiac function according to residual renal function in patients on hemodialysis with urination.Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study.Emerging importance of residual renal function in end-stage renal failure.Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.Baseline and Time-Averaged Values Predicting Residual Renal Function Decline Rate in Japanese Peritoneal Dialysis Patients.Phosphate Removal by Peritoneal Dialysis: The Effect of Transporter Status and Peritoneal Dialysis Prescription.Influence of Residual Renal Function in Carotid Modeling as a Marker of Early Atherosclerosis in Dialysis Patients.Better preservation of residual renal function in peritoneal dialysis patients treated with a low-protein diet supplemented with keto acids: a prospective, randomized trial.Biomarkers Associated with Vascular Calcification in Peritoneal Dialysis.
P2860
Q28552675-A64294D9-B3B8-4D83-8023-B2001C56C35AQ34639575-F274F388-8E10-4100-A734-D1F4A7DCF806Q34857892-B02B1FE9-B191-419B-BB8D-ADED25055ADCQ35499669-B322958F-46DE-4676-8627-75B539BB4938Q35695757-3E10076E-97EF-4170-BC6E-3B4727242CABQ36492520-02D9D3F0-1B60-4EDE-95A5-63E3A208BC5AQ36947323-0A2F5B65-FE6B-49C2-AE09-0806B33BE267Q37352176-83A8B0E6-4865-42E5-A02A-FE57461A0119Q37378439-43C7CEFB-B482-434E-B3A4-44C501C33511Q37682811-2467AFEA-FE5D-463E-B7CE-94C2A9192963Q37787773-9FFA22C5-7B5D-46E1-BD50-FD8943374B19Q37914009-25868E7E-4485-4828-AD3D-AFEC4F45040CQ38122625-EF7A6FDD-475F-405A-8129-B7A7791DCAB8Q38861577-FBF087A5-6000-485A-B357-D20749FC67BDQ42365194-C40C797D-7CB4-4862-B4BA-3F42F9A96B43Q43144754-2736DFE7-773B-4780-B9C9-0FBFDEA1C608Q44232525-939F0178-2807-4DFF-9D87-7531DAF6D784Q46344305-7F5635D6-CC7D-41C8-B05E-3978096267FAQ47630860-323D37FC-C503-440E-9BE6-D64088BCC202Q50531608-C1DD1117-BD34-4D48-ABB4-C1ECCF7AEA64Q50887096-A18D2102-8F3A-42A4-85D1-C6099CDC8EA2Q51788326-BF1A4238-A3B6-43D9-A76F-A885174A62A4Q53378011-6BAE59BB-3134-433C-8DFB-BDE4EF180834
P2860
Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Hyperphosphatemia in Chinese p ...... on: what are the implications?
@en
Hyperphosphatemia in Chinese p ...... on: what are the implications?
@nl
type
label
Hyperphosphatemia in Chinese p ...... on: what are the implications?
@en
Hyperphosphatemia in Chinese p ...... on: what are the implications?
@nl
prefLabel
Hyperphosphatemia in Chinese p ...... on: what are the implications?
@en
Hyperphosphatemia in Chinese p ...... on: what are the implications?
@nl
P2093
P1476
Hyperphosphatemia in Chinese p ...... on: what are the implications?
@en
P2093
Angela Yee-Moon Wang
Man-Ching Law
Mandy Man-Mei Sea
Philip Kam-Tao Li
Siu-Fai Lui
P304
P356
10.1053/J.AJKD.2003.12.032
P50
P577
2004-04-01T00:00:00Z